Clinical Trials Directory

Trials / Unknown

UnknownNCT00131053

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients With BCR-ABL-Negative Acute Lymphoblastic Leukemia

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Japan Adult Leukemia Study Group · Academic / Other
Sex
All
Age
15 Years – 24 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

Detailed description

The prognosis for adult acute lymphoblastic leukemia (ALL) remains poor, which contrasts with that for pediatric ALL. It is regarded that the prognostic diversity is attributable to several differences between adults and children with respect to biological characteristics of leukemic cells, tolerance to anticancer drugs, treatment itself, and so on. It has been reported that adolescent ALL patients who were treated according to the pediatric protocol had a significantly better survival than those who were treated according to the adult protocol, indicating that the difference of treatment may be of considerable importance. To test the hypothesis, the Japan Adult Leukemia Study Group (JALSG) has planned a phase 2 study to treat younger ALL patients who are negative for BCR-ABL with the pediatric regimen which was used by the Japan Association of Childhood Leukemia Study. Those who are positive for BCR-ABL can participate in a separate protocol. The regimen is especially characterized by dose-intensified L-asparaginase, high-dose methotrexate, and intensified maintenance therapy.

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate
DRUGPrednisolone
DRUGDexamethasone
DRUGVincristine
DRUGPirarubicin
DRUGCyclophosphamide
DRUGL-asparaginase
DRUGCytarabine
DRUGHydrocortisone
DRUGMercaptopurine

Timeline

Start date
2002-09-01
Primary completion
2011-05-01
Completion
2011-09-01
First posted
2005-08-17
Last updated
2008-11-14

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00131053. Inclusion in this directory is not an endorsement.